Sign in

Private company

AKUMIN INC.

AKUMIN INC. is a Canadian medical laboratories services company, incorporated in Ontario.1 It is headquartered in Plantation, Florida.1

Last updated Oct 21, 2026.

Overview

  • IndustryServices-Medical Laboratories1
  • HeadquartersPlantation, Florida1
  • Incorporated inOntario, Canada2
  • Business address8300 W Sunrise Blvd, Plantation, Fl 333222
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-3.7%Operating margin3
-20.9%Net margin3
78.0%Revenue growth, 20223
$20.6MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Other costs83¢$623.2M
  • Interest16¢$118.0M
  • Income tax1¢$8.4M

Out of $749.6M in revenue.3 The company lost money this year.

Where each dollar of operating cash went, fiscal 2022

  • Capital spending68¢$44.8M
  • Kept or used elsewhere32¢$20.6M

Out of $65.4M of cash from operations.3

Financial statements

Revenue43$749.6M in 2022+243% since 2019
0$200.0M$400.0M$600.0M$800.0M2019: $218.4M$218.4M20192020: $238.3M$238.3M2020+9%2021: $421.1M$421.1M2021+77%2022: $749.6M$749.6M2022+78%
Operating income453-$28.1M in 2022
-$40.0M-$20.0M0$20.0M$40.0M2019: $9.7M$9.7M20192020: $25.0M$25.0M2020+158%2021: $13.6M$13.6M2021−45%2022: -$28.1M-$28.1M2022
Net income453-$156.8M in 2022+1112% since 2019
-$200.0M-$150.0M-$100.0M-$50.0M02019: -$12.9M-$12.9M20192020: -$36.7M-$36.7M2020+184%2021: -$43.3M-$43.3M2021+18%2022: -$156.8M-$156.8M2022+262%
Fiscal year20182019202020212022
Revenue$218.4M4$238.3M4$421.1M3$749.6M3
Operating expenses$407.5M3$777.7M3
Operating income$9.7M4$25.0M5$13.6M3-$28.1M3
Interest$20.8M4$32.8M5$62.6M3$118.0M3
Income before tax-$65.2M3-$143.2M3
Income tax-$2.8M4$562.0K5-$30.4M3$8.4M3
Net income-$12.9M4-$36.7M5-$43.3M3-$156.8M3
Earnings per share-$0.563-$1.753
Earnings per share (diluted)-$0.563-$1.753
Shares (weighted, basic)76.8M shares389.5M shares3
Shares (weighted, diluted)76.8M shares389.5M shares3

Compare AKUMIN INC. with another company

Corporate structure

AKUMIN INC. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of AKUMIN INC.

  • AKUMIN INC. Plantation, Florida

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What AKUMIN INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$337.4M5 Dec 31, 2021$106.9M5 Dec 31, 2020+215.7%
Accumulated depreciation$78.3M5 Dec 31, 2021$43.2M5 Dec 31, 2020+81.4%
Property and equipment, net$259.1M5 Dec 31, 2021$63.7M5 Dec 31, 2020+306.7%
Finance-lease assets$26.3M3 Dec 31, 2022$29.1M3 Dec 31, 2021−9.6%
Operating-lease assets (leased space)$166.8M3 Dec 31, 2022$194.6M3 Dec 31, 2021−14.3%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$59.4M3 Dec 31, 2022$48.4M3 Dec 31, 2021+22.7%
Stakes in other companies (equity method)$7.9M3 Dec 31, 2022$7.9M5 Dec 31, 20210%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$769.1M3 Dec 31, 2022$840.4M3 Dec 31, 2021−8.5%
Intangible assets, net (excluding goodwill)$392.1M3 Dec 31, 2022$414.1M3 Dec 31, 2021−5.3%
Indefinite-lived intangibles (excluding goodwill)$69.6M3 Dec 31, 2022$69.6M3 Dec 31, 20210%
Finite-lived intangibles, gross$356.4M3 Dec 31, 2022$358.7M3 Dec 31, 2021−0.6%
Accumulated amortization$33.9M3 Dec 31, 2022$14.1M3 Dec 31, 2021+140.2%
Finite-lived intangibles, net$322.5M3 Dec 31, 2022$344.6M3 Dec 31, 2021−6.4%

Leadership

Who has led AKUMIN INC., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Riadh Zine2022–2023

President

  1. Douglas McCracken2022

Chief financial officer

  1. R. David Kretschmer2023
2025
Board members and other officers (20)

Timeline

  1. Feb 7, 20248-K Entered a material agreement; Ended a material agreement; Bankruptcy or receivership30
  2. Jan 2, 20248-K Executive or director change; Regulation FD disclosure31
  3. Dec 12, 20238-K Regulation FD disclosure32
  4. Dec 5, 20238-K Bankruptcy or receivership; New debt or obligation; Other events33
  5. Nov 2, 20238-K Regulation FD disclosure34
  6. Oct 27, 20238-K Bankruptcy or receivership; Debt or obligation accelerated; Listing notice or transfer35
  7. Oct 23, 20238-K Bankruptcy or receivership; Debt or obligation accelerated; Other events36
  8. Oct 20, 20238-K Entered a material agreement; Listing notice or transfer; Executive or director change37
  9. Oct 16, 20238-K Entered a material agreement; Other events38
  10. Oct 5, 20238-K Entered a material agreement39
  11. Sep 13, 20238-K Executive or director change40
  12. Aug 21, 20238-K Listing notice or transfer41
  13. Jan 4, 2022New chief executive Riadh Zine becomes CEO9

Calendar

When it reported results

  1. Aug 9, 2023Reported quarterly or annual results42
  2. May 10, 2023Reported quarterly or annual results43
  3. Mar 16, 2023Reported quarterly or annual results44
  4. Nov 9, 2022Reported quarterly or annual results45
  5. Aug 9, 2022Reported quarterly or annual results46
  6. May 10, 2022Reported quarterly or annual results47
  7. Mar 17, 2022Reported quarterly or annual results48

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

167 filings to the SEC since October 2021: 4 annual reports, 6 quarterly reports, 36 major events, 58 insider forms, 16 large holders, 47 other. The latest 20:

  1. Feb 12, 2024EFFECT EDGAR
  2. Feb 12, 2024SC 13G/A EDGAR
  3. Feb 12, 2024SC 13G EDGAR
  4. Feb 7, 2024SC 13G/A EDGAR
  5. Feb 7, 2024SC 13G/A EDGAR
  6. Feb 7, 202415-12G EDGAR
  7. Feb 7, 2024S-8 POS EDGAR
  8. Feb 7, 2024POS AM EDGAR
  9. Feb 7, 20248-K EDGAR
  10. Feb 5, 20243 EDGAR
  11. Jan 2, 20248-K EDGAR
  12. Dec 12, 202310-Q EDGAR
  13. Dec 12, 20238-K EDGAR
  14. Dec 5, 20238-K EDGAR
  15. Nov 14, 2023NT 10-Q EDGAR
  16. Nov 2, 20238-K EDGAR
  17. Oct 27, 20238-K EDGAR
  18. Oct 26, 20233 EDGAR
  19. Oct 25, 2023SC 13D/A EDGAR
  20. Oct 23, 20238-K EDGAR

The 167 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

11 open-market trades by officers, directors and large owners since October 2021: 7 buys and 4 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 30, 2022KRETSCHMER R. DAVIDChief Financial OfficerBuy5,338$1.33$7.1KForm 4
Aug 29, 2022KRETSCHMER R. DAVIDChief Financial OfficerBuy6,500$1.38$9.0KForm 4
Aug 19, 2022KRETSCHMER R. DAVIDChief Financial OfficerBuy2,500$1.07$2.7KForm 4
Aug 18, 2022KRETSCHMER R. DAVIDChief Financial OfficerBuy17,500$1.14$19.9KForm 4
Aug 18, 2022Lee MurrayDirectorBuy26,000$1.15$29.8KForm 4
Jul 21, 2022SCW Capital Management, LP10% ownerBuy3,065,257$0.52$1.6MForm 4
Jul 21, 2022SCW Capital Management, LP10% ownerSale3,065,257$0.52$1.6MForm 4
Mar 9, 2022SCW Single-Asset Partnership QP, LP10% ownerSale16,000$0.97$15.5KForm 4
Mar 8, 2022SCW Single-Asset Partnership QP, LP10% ownerSale4,304$1.00$4.3KForm 4
Jan 7, 2022Cathey Robert N.10% ownerBuy75,000$1.66$124.5KForm 4
Jan 7, 2022Cathey Robert N.10% ownerSale75,000$1.66$124.5KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How AKUMIN INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAKUMIN INC.1
  • CIK0001776197
  • Filer status<br>emerging growth company1
  • Incorporated inOntario, Canada1
  • Fiscal year endsDecember 311
  • Industry code (SIC)8071 Services-Medical Laboratories1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address8300 W Sunrise Blvd, Plantation, FL 333221
  • Phone95467844891
  • Shares outstanding91,173,491 as of Dec 4, 20238
  • Public float$35.6M as of Jun 30, 20223
  • On EDGAR sinceAug 28, 20201
  • Filings214 in all: 6-K (43), 8-K (36), 3 (29), 4 (28), SC 13G/A (13), 10-Q (6), EFFECT (6), SC 13G (6)1
    All 38 form types

    POS AM (5), 424B3 (3), DEFA14A (3), S-8 POS (3), SC 13D (3), 10-K (2), 40-F/A (2), CORRESP (2), SC 13D/A (2), UPLOAD (2), 10-K/A (1), 15-12G (1), 25-NSE (1), 3/A (1), 40-F (1), 40FR12B (1), 425 (1), 6-K/A (1), ARS (1), CERT (1), D (1), DEF 14A (1), F-3 (1), F-X (1), NT 10-Q (1), PRE 14A (1), S-4 (1), S-4/A (1), S-8 (1), SEC STAFF ACTION (1)

  • Latest filingsAnnual report (10-K) Mar 16, 2023
    Quarterly report (10-Q) Dec 12, 2023
    Proxy statement (DEF 14A) Apr 28, 2023
    Latest 8-K (8-K) Feb 7, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56